SENSEX 73198.1 (-1.90)
Nifty 50 22124.7 (-1.86)
Nifty Bank 48344.7 (-0.82)
Nifty IT 37318.3 (-4.18)
Nifty Midcap 100 47915.2 (-2.49)
Nifty Next 50 57063.05 (-2.90)
Nifty Pharma 19813.5 (-1.92)
Nifty Smallcap 100 14700.2 (-3.01)
NIKKEI 225 37155.5 (-2.88)
HANG SENG 22941.32 (-3.28)
S&P 5975.25 (1.48)
BSE Code : 532523 | NSE Symbol : BIOCON | ISIN : INE376G01013 | Industry : Pharmaceuticals |
Hot Pursuit 28-Feb-2025 (09:58) Biocon launches blood sugar regulating drug Liraglutide in U.K.
Corporate News 28-Feb-2025 (10:01) Biocon launches GLP-1 peptide, Liraglutide in the UK
Hot Pursuit 25-Feb-2025 (09:37) Biocon gains after arm launches YESINTEK Biosimilar in U.S. Market
Hot Pursuit 20-Feb-2025 (13:35) Biocon Ltd eases for fifth straight session
Hot Pursuit 18-Feb-2025 (09:30) Biocon's Ustekinumab biosimilar gets marketing authorisation for EU region
Biocon 01-Feb-2025
Biocon 09-Aug-2024
Biocon 17-May-2024
Total Foreign
Total Institutions
Total Govt Holding
Total Non Promoter Corporate Holding
Total Promoters
Total Public & others